The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer.

O'Sullivan, Joe M; Heinrich, Daniel; James, Nicholas D; Nilsson, Sten; Ost, Piet; Parker, Christopher C; Tombal, Bertrand

O'Sullivan, Joe M; Heinrich, Daniel; James, Nicholas D; Nilsson, Sten; Ost, Piet; Parker, Christopher C; Tombal, Bertrand.

Afiliación

O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University, Belfast City Hospital, Belfast, UK. Electronic address: joe.osullivan@qub.ac.uk.
Heinrich D; Akershus University Hospital, Lørenskog, Norway.
James ND; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Nilsson S; Karolinska Hospital, Stockholm, Sweden.
Ost P; Ghent University, Ghent, Belgium.
Parker CC; Institute of Cancer Research, Sutton, UK.
Tombal B; Université Catholique de Louvain, Louvain, Belgium.

Eur Urol ; 75(3): e51-e52, 2019 03.

Article en En | MEDLINE | ID: mdl-30454914

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Eur Urol Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Eur Urol Año: 2019 Tipo del documento: Article